Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Record is Archived

    This article is now archived and is closed to further replies.

    Jefferson Adams
    Jefferson Adams

    BioLineRx Clears Latest Hurdle for Celiac Treatment Drug

    Reviewed and edited by a celiac disease expert.
    BioLineRx Clears Latest Hurdle for Celiac Treatment Drug - Photo: Wikimedia Commons--CitrusZest
    Caption: Photo: Wikimedia Commons--CitrusZest

    Celiac.com 12/09/2014 - Biopharmaceutical company BioLineRx Ltd., has announced successful final results from its Phase 1/2 study for BL-7010, a novel co-polymer for the treatment of celiac disease.

    Photo: Wikimedia Commons--CitrusZestBL-7010 is a new, non-absorbable, orally available co-polymer intended for the treatment of celiac disease. The drug works by sequestering gliadins, effectively masking them from enzymatic degradation and preventing the formation of immunogenic peptides that trigger an adverse immune reaction when people with celiac disease consume wheat.

    Celiac.com Sponsor (A12):
    This significantly reduces the immune response triggered by gluten. BL-7010 is excreted with gliadin from the digestive tract and is not absorbed into the blood.

    The trial results showed BL-7010 to be safe and well tolerated in both single- and repeated-doses, and pharmacokinetic analyses revealed no systemic exposure of BL-7010 in plasma and urine samples.

    The company has also settled on a one gram, three times per day regimen of BL-7010 as the optimal repeated dose for an upcoming randomized, placebo-controlled efficacy study set to begin in the last half of 2015.

    The absence of systemic exposure will likely support a medical-device classification for BL-7010, which would significantly accelerate its development in Europe.


    Source:

    • Open Original Shared Link


    User Feedback

    Recommended Comments

    Guest Tina K

    That's nice, however, I will not use it. Why should I pay to take a drug for the rest of my life just so I can eat gluten-containing foods which really aren't good for you anyway and cause more health problems. Sounds like a lose-lose situation to me.

    Link to comment
    Share on other sites
    Guest Carol August

    Posted

    Article worth the time/effort to read it. Perhaps a bit more thorough explanation of the chemistry of this new drug could be helpful to the lay person.

    Thank you.

    Link to comment
    Share on other sites
    Guest Angela Thompson

    Posted

    How long will it be before BL-7010 is approved by the FDA in the US? I need relief from the celiac symptoms. I am ultra sensitive even to a lot of the gluten free products. I have lost down to 112lbs. I weighed 122 almost 9 months ago.

    Link to comment
    Share on other sites
    Guest muriel

    This is GREAT news!!!

    Link to comment
    Share on other sites
    Guest Phyllis Smoker

    Posted

    How long will it be before BL-7010 is approved by the FDA in the US? I need relief from the celiac symptoms. I am ultra sensitive even to a lot of the gluten free products. I have lost down to 112lbs. I weighed 122 almost 9 months ago.

    I also am sensitive to a lot of gluten-free foods. I have found out it is the mono and diglicerides that are used in manufacturing. Mono glicerides are OK, but eliminate foods with mono and diglicerides, see if that helps you. It has helped me.

    Link to comment
    Share on other sites
    Guest Rob
    That's nice, however, I will not use it. Why should I pay to take a drug for the rest of my life just so I can eat gluten-containing foods which really aren't good for you anyway and cause more health problems. Sounds like a lose-lose situation to me.

    Wrong! - every time you don't prepare everything you eat from scratch you risk a gluten exposure. The amount for a Coeliac reaction is so tiny (one breadcrumb) and the time to repair (6 to 12 months) so long this would help ensure you keep yourself safe. No matter how careful a Coeliac is - this is a very useful product. Cant wait...

    Link to comment
    Share on other sites
    Guest Wayne Boswell

    Posted

    I might be interested in such a drug, if it is performing a function that the normal (non-celiac) body performs. I've never read anything as to how the non-celiacs body handles gluten (gliadin). I did appreciate the comment on digicerides, and plan to attempt that. Still looking for answers 20 years after celiac diagnosis.

    Link to comment
    Share on other sites
    Guest Andrea

    The celiac situation is so complex and there is so much that remains unknown. The danger with a drug to treat part of a problem doesn't allow intelligent consumer choices. For instance for a great many celiacs, the casein in dairy products causes similar symptoms. There is too great a similarity between the proteins in casein, corn even other grains originally thought to be safe for celiacs. So lets say you take a drug that handles gliadin and you think, "Great" now I can eat anything. Not really. You may take chances with wheat because of the drug and never know that you are causing damage because of the other proteins. You are also ingesting a chemical which needs years of trials and after market testing to show the real side effects. There is so much great whole food to eat, why stay so heavily focused on wheat induced happiness?

    Link to comment
    Share on other sites
    Guest Peter Olins

    Posted

    How long will it be before BL-7010 is approved by the FDA in the US? I need relief from the celiac symptoms. I am ultra sensitive even to a lot of the gluten free products. I have lost down to 112lbs. I weighed 122 almost 9 months ago.

    Hi Angela. This drug is still in the early stages of clinical development. The latest study was simply to test for safety at different doses, and to measure if the drug was absorbed by the body. It did not address whether the drug actually works. Sadly, a large majority of drugs that reach this stage of development never reach the market, due to safety or efficacy problems. In other words, while this work is exciting, we are still a long way from being able to celebrate.

    Link to comment
    Share on other sites


    Guest
    This is now closed for further comments

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Jefferson Adams

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

    >VIEW ALL ARTICLES BY JEFFERSON ADAMS

     


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Destiny Stone
    Is Intestinal Biopsy Avoidable in Diagnosing Celiac Disease?
    Celiac.com 07/14/2010 - Intestinal biopsy is considered the the gold standard for celiac disease testing. However, biopsy is an  invasive procedure and most people would be happy to avoid biopsy all together. Based solely on serology, a new diagnostic standard  has been proposed that would no longer require intestinal biopsy for celiac disease diagnosis in some patients.
    Researchers performed duodenal biopsy and serology in six-hundred and seventy-nine adults who were at high risk and low risk for celiac disease. They tested blood samples  to detect antibodies to tissue transglutaminase (tTG) and deamidated gliadin peptide (DGP). The goal of researchers was to establish the diagnostic performance of various serological tests for diagnosing celiac disease in patients with varying pretest re...


    Destiny Stone
    Celiac.com 08/11/2010 - New studies from the United States, Europe and other Countries around the world indicate that the commonness of celiac disease has dramatically increased  in the last decade, possibly as much as four-times the amount seen in the 1950's. Most current studies show that celiac disease is prevalent in at least 1% of the general population.
    To determine when the prevalence of celiac disease started to increase, researchers at the Mayo Clinic analyzed blood samples stored from Air Force recruits taken in the early 1950's, and compared them with blood samples from this decade. Expecting to see at least 1% of the samples come up positive for gluten antibodies, they were surprised to find the numbers were much smaller than anticipated. The results of these studies suggest ...


    Diana Gitig Ph.D.
    ImmusanT's Celiac Vaccine Passed Phase I Clinical Trials
    Celiac.com 05/23/2011 - ImmusanT, Inc., a biotechnology start up based in Cambridge, Massachusetts, is testing a vaccine to desensitize celiac patients to gluten. It is called Nexvax2, and it has already passed Phase I clinical trials, which means that it is safe and tolerable to humans. Nexvax2 is slated to begin Phase II trials, which address efficacy, within the next year.
    Nexvax2 was developed by Nexpep Pty, Ltd., a company in Melbourne, Australia. It is based on their findings that only three peptides are responsible for eliciting the majority of the T cell response that goes on to destroy the intestines of celiac patients. HLA molecules function to present these toxic peptides to T cells; this presentation is what activates the T cells, instigating the inflammatory response. Thus...


    Tina Turbin
    Celiac Disease Prevalence is on the Rise
    Celiac.com 10/12/2011 - According to recent estimates, three million Americans suffer from celiac disease—approximately 1% of the population, and only three percent of them have to this writing been correctly diagnosed. As startling as that sounds to us all, according to a news article on Medscape Today, the incidence of celiac disease has increased markedly over the last three decades, perhaps even as fourfold, and studies are suggesting the incidence may actually be higher than 1% of the population.
    What is the reason for this? According to Dr. Jonas Ludvigsson, MD, from the Department of Medicine, Epidemiology Unit at the Karolinska Institute and Orebro University Hospital in Sweden, and a renowned celiac expert, there may be many factors explaining this, but there probably is an a...


  • Recent Activity

    1. - trents replied to Art Maltman's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      My 5 months of Struggle

    2. - Scott Adams replied to Dana Gilcrease's topic in Gluten-Free Foods, Products, Shopping & Medications
      4

      Gluten-Free Foods

    3. - Art Maltman posted a topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      My 5 months of Struggle


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,492
    • Most Online (within 30 mins)
      7,748

    DebDeb
    Newest Member
    DebDeb
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.4k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • JA917
      11
    • Dana Gilcrease
      4
    • marion wheaton
      6
    • Jula
    • GardeningForHealth
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...